日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ONC201 (Dordaviprone) Induces Integrated Stress Response and Death in Cervical Cancer Cells

ONC201(多达韦普隆)诱导宫颈癌细胞产生整合应激反应并导致其死亡

Pathak, Sneha O; Manohar, Sonal M

Combination of the First-in-Class Imipridone ONC201 and Standard Anticancer Therapies as a Rational Approach for Therapeutic Benefit

将首创药物伊米普利酮 ONC201 与标准抗癌疗法联合使用,是一种合理的治疗获益策略

Shenoy, Brahmi; Mandani, Miloni; Chintamaneni, Meena; Manohar, Sonal M

Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers

分子证据表明,吉西他滨联合细胞周期蛋白依赖性激酶抑制剂P276-00可增强其在胰腺癌中的抗肿瘤活性

Rathos, Maggie J; Joshi, Kavita; Khanwalkar, Harshal; Manohar, Sonal M; Joshi, Kalpana S

A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells

一种新型的缺氧诱导因子-1α抑制剂P3155也能调节PI3K通路并抑制前列腺癌细胞的生长。

Manohar, Sonal M; Padgaonkar, Amol A; Jalota-Badhwar, Archana; Sonawane, Vinay; Rathos, Maggie J; Kumar, Sanjay; Joshi, Kalpana S